OCCIDENT
Venture capitalMunich · Pre-Seed–Series A · 4 people tracked
Investment thesis
OCCIDENT invests in deep-tech startups that transfer promising scientific findings into concrete applications, financing spin-offs from research whose innovations address societal challenges and create value. The firm invests its own capital, takes a long-term view focused on sustainable success potential, and supports portfolio companies financially and with entrepreneurial experience. Its focus areas include life sciences and biotechnology as well as industrial tech. Positioning itself as 'The Science Investor,' OCCIDENT emphasizes an entrepreneurial mindset in portfolio management, from deal sourcing and due diligence through closing and active support, aiming to bring innovations to market success 'the OCCIDENT way.'
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from the firm's website
What they invest in
from 12 of 20 portfolio companiesMedical Devices ×9Biotech ×7Deep Tech ×5Healthtech ×3Advanced Manufacturing ×2Digital Health ×2Hardware ×2AI & Machine Learning ×1
HQs:Switzerland×5Germany×4
Investments · 20 tracked
founders shown can be your intro pathAlgiax Pharmaceuticals is a clinical-stage biotech company developing small-molecule GABAA receptor modulators to treat neuropathic pain and other conditions with high unmet medical need.
BiotechMedical DevicesErkrath, DE
Dr. Guido Koopmans(Chief Scientific Officer)Dr. Birgit Hasse(Head of CMS and Regulator Affairs)
Immitra Bio develops an in-vivo stem cell therapy platform designed to treat rare genetic diseases, particularly severe inherited red blood cell disorders, by replacing complex transplants with single off-the-shelf treatments.
BiotechDeep TechMedical DevicesZürich, CH
Jan Nelis(CEO)in
Co-investorsKickfundanother.vcBackbone VenturesVenture Kick
Altavo develops non-invasive silent speech technology using RF sensing and artificial intelligence to help patients who have lost their voice regain natural-sounding speech.
AI & Machine LearningDeep TechMedical DevicesDresden, DE
Rudolf
Co-investorsNovalis Biotech
Avelo develops diagnostic technology aimed at closing the diagnostic gap in respiratory disease, so patients receive timely and accurate information for effective treatment.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsPrivilège Ventures
Chipmetrics provides 3D metrology solutions using test chips and wafers for semiconductor process control, serving semiconductor manufacturers and material developers optimizing deposition processes and yields.
Advanced ManufacturingDeep TechHardwareSemiconductors
Feng Gao(Founder)in
Co-investorsInnovestor VenturesRedstone
Core Sensing develops integrated wireless sensor systems that measure force, torque, and other physical quantities directly on components, delivering data to cloud platforms and dashboards for condition monitoring and predictive maintenance applications.
Advanced ManufacturingHardwareIoT
EBAMed develops non-invasive cardiac ablation technology using particle/proton beam therapy to treat cardiac arrhythmias, with in-house R&D focused on medical devices and cardiac software.
HealthtechMedical Devices
Giovanni Leo(Co-Founder)Douglas Packer(Co-Founder & Key Advisor)Ugo Amaldi(Co-Founder & Key Advisor)Marina Izzo(Chief Executive Officer & Director)inAdriano Garonna(Chief Technology Officer)inOlivier Coquoz(Head of R&D)
Co-investorsElysia CapitalLIFTT
Startup that credited Venture Kick with helping establish its customer and market focus.
Co-investorsSICTICVenture Kick
Lunaphore provides spatial biology technology for research labs, enabling multiplexed immunohistochemistry (IHC) analysis with existing antibodies.
BiotechDeep TechMedical DevicesLausanne, CH
Co-investorsZühlke Ventures
Co-investorsCDP Venture Capital
Resistell develops a nanomotion-based diagnostic device for rapid phenotypic antibiotic susceptibility testing (AST), aimed at accelerating detection of antibiotic resistance in hospital settings.
BiotechHealthtechMedical Devices
Dr. Danuta Cichocka(CEO, Co-Founder, Board Member)inGrzegorz Gonciarz(COO)inDr. Alex Sturm(Chief Scientific Officer)inMartin Birk(CFO)in
Co-investorsAlpana Ventures
Co-investorsBayern Kapital
The page is a placeholder shell showing only cookie/consent notices for embedded third-party content (Vimeo, YouTube, reCAPTCHA, social media) and contains no substantive information about the company.
Co-investorsAndera PartnersBioMedPartnersFrazier Life SciencesFund+Nextech Invest
BiotechDigital HealthMedical Devices
Co-investorsVerve Ventures
Exits · 2
IPOs and acquisitions across the tracked portfolioTubulis GmbHacq. by Gilead SciencesVersantisacq. by GENFIT
Portfolio news
latest coverage across their companiesChip Metrics · chipmetrics.com · Dec 3, 2025
Frequently asked questions
- How many investments has OCCIDENT made?
- OCCIDENT has 20 tracked investments, 2 of which have exited via acquisition or IPO.
- What stage does OCCIDENT invest at?
- OCCIDENT invests at the Pre-Seed, Seed, Series A stages.
- What sectors does OCCIDENT focus on?
- OCCIDENT focuses on Advanced Manufacturing, Biotech, Deep Tech, Hardware, Healthtech.
- Where is OCCIDENT located?
- OCCIDENT is headquartered in Munich, DE.
- Who does OCCIDENT co-invest with?
- OCCIDENT most often shares deals with SICTIC, CDP Venture Capital, Frazier Life Sciences, among 19 tracked co-investors.
Similar investors
Zhejiang Haibang Private Fund Management Co., Ltd. (formerly Zhejiang Haibang Investment Management Co., Ltd.) is a Chinese venture capital firm founded in 2011 that focuses on backing returnee-entrepreneur startups in hard-tech and early-stage ventures.
Taiwan Global Angels (TGA) is a global network of angel investors based mainly in the US and Taiwan that backs early-stage startups with scalable technologies leveraging Taiwan's strengths in manufacturing, healthcare, distribution channels, and talent.
Unruly Capital is a venture firm that backs founders working on ideas that seem too early or unconventional but are expected to become mainstream within a decade, focusing on frontier technology themes.
North Forge is a Canadian non-profit startup incubator, accelerator, and fabrication lab that supports technology, STEM, and advanced manufacturing founders from ideation through Series A without taking equity.
Redstart Labs is an early-stage venture capital firm founded in 2020 as a subsidiary of InfoEdge that invests in startups built on deep scientific and technological foundations. The firm focuses on deep tech companies across autonomous systems, aerospace, applied intelligence, synthetic biology, foundational infrastructure, clean energy, and human-computer interaction.